PetIQ, Inc. - (PETQ): Price and Financial Metrics

PetIQ, Inc. - (PETQ): $36.01

-0.11 (-0.30%)

POWR Rating

Component Grades














  • Growth is the dimension where PETQ ranks best; there it ranks ahead of 98.47% of US stocks.
  • The strongest trend for PETQ is in Stability, which has been heading up over the past 31 weeks.
  • PETQ's current lowest rank is in the Quality metric (where it is better than 6.92% of US stocks).

PETQ Stock Summary

  • Price to trailing twelve month operating cash flow for PETQ is currently 158.35, higher than 97.37% of US stocks with positive operating cash flow.
  • Of note is the ratio of PetIQ Inc's sales and general administrative expense to its total operating expenses; 96.9% of US stocks have a lower such ratio.
  • Over the past twelve months, PETQ has reported earnings growth of -328.48%, putting it ahead of just 6.34% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to PetIQ Inc are VREX, EVC, RLGY, RRC, and DLA.
  • PETQ's SEC filings can be seen here. And to visit PetIQ Inc's official web site, go to

PETQ Valuation Summary

  • In comparison to the median Healthcare stock, PETQ's price/sales ratio is 65.85% lower, now standing at 1.4.
  • PETQ's price/sales ratio has moved down 0.9 over the prior 48 months.
  • PETQ's price/earnings ratio has moved up 122.1 over the prior 48 months.

Below are key valuation metrics over time for PETQ.

Stock Date P/S P/B P/E EV/EBIT
PETQ 2020-03-06 1.2 2.8 -205.1 165.4
PETQ 2019-12-05 1.0 2.3 -167.5 142.7
PETQ 2019-10-14 1.2 2.6 178.7 62.7
PETQ 2019-08-16 1.5 3.2 217.5 75.0
PETQ 2018-11-01 2.1 6.0 -281.9 176.1
PETQ 2018-01-02 2.4 6.8 -140.0 -1333.2

PETQ Price Target

For more insight on analysts targets of PETQ, see our PETQ price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $49.80 Average Broker Recommendation 1.17 (Strong Buy)

PETQ Stock Price Chart Interactive Chart >

Price chart for PETQ

PETQ Price/Volume Stats

Current price $36.01 52-week high $46.00
Prev. close $36.12 52-week low $24.42
Day low $35.22 Volume 213,808
Day high $36.51 Avg. volume 341,248
50-day MA $38.83 Dividend yield N/A
200-day MA $35.61 Market Cap 1.05B

PetIQ, Inc. - (PETQ) Company Bio

PetIQ, Inc. manufactures and distributes health and wellness products for dogs and cats. The Company offers pet prescription medications, over-the-counter flea and tick preventives, health and wellness supplements, and dog and cat treats. The company is based in Eagle, Idaho.

PETQ Latest News Stream

Event/Time News Detail
Loading, please wait...

PETQ Latest Social Stream

Loading social stream, please wait...

View Full PETQ Social Stream

Latest PETQ News From Around the Web

Below are the latest news stories about PetIQ Inc that investors may wish to consider to help them evaluate PETQ as an investment opportunity.

PetIQ, Inc. to Report Second Quarter 2021 Financial Results on Wednesday, August 4, 2021

EAGLE, Idaho, July 22, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the second quarter ended June 30, 2021, on Wednesday, August 4, 2021, after the market close.

Intrado Digital Media | July 22, 2021

NVST vs. PETQ: Which Stock Should Value Investors Buy Now?

NVST vs. PETQ: Which Stock Is the Better Value Option?

Yahoo | July 20, 2021

Medtronic (MDT) Diabetes Arm Grows With Favorable InPen Data

Medtronic's (MDT) InPen is a FDA as well as CE Mark-cleared smart insulin pen available for patients who require multiple daily injections.

Yahoo | June 29, 2021

Pandemic Boosts Animal Health Spending: 4 Stocks to Buy

Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.

Yahoo | June 29, 2021

Insulet (PODD) Reports Positive Study Outcomes on Omnipod 5

Insulet's (PODD) Omnipod 5 shows improved glycemic outcomes for users of all age groups and reduced diabetes distress in users and respective caregivers amid other benefits.

Yahoo | June 29, 2021

Read More 'PETQ' Stories Here

PETQ Price Returns

1-mo -10.40%
3-mo -18.03%
6-mo -1.29%
1-year -0.66%
3-year 30.95%
5-year N/A
YTD -6.35%
2020 53.49%
2019 6.73%
2018 7.46%
2017 N/A
2016 N/A

Continue Researching PETQ

Want to see what other sources are saying about PetIQ Inc's financials and stock price? Try the links below:

PetIQ Inc (PETQ) Stock Price | Nasdaq
PetIQ Inc (PETQ) Stock Quote, History and News - Yahoo Finance
PetIQ Inc (PETQ) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8569 seconds.